Table 4.

Comparison of doses to active whole pelvic and lumbar-sacral bone marrow (defined with ¹⁸FDG-PET) among the 4 plans

		Plan A		Plan B		Plan C		Plan D		p ≤ 0.05 ANOVA	Fisher-Hayter test
Structure	Parameter	Mean	SD(+/−)	Mean	SD(+/−)	Mean	SD(+/−)	Mean	SD(+/−)
ACTPBM	D max	52.67	2.72	52.93	2.82	53.03	2.79	53.18	2.63	NS
	D mean	29.33	2.38	26.99	2.38	25.76	2.74	26.02	2.69	0.014	A vs C and D
	V 5	94.59	4.23	92.85	5.05	92.57	5.32	92.71	5.11	NS
	V 10	87.84	6.04	85.10	7.10	84.05	7.73	84.35	7.53	NS
	V 15	82.82	7.06	78.54	7.52	75.17	9.14	75.82	8.44	NS
	V 20	74.26	7.13	68.58	6.94	63.50	8.59	64.24	8.43	0.015	A vs C and D
	V 25	63.49	7.48	56.35	6.90	51.49	7.52	52.18	7.97	0.030	A vs C and D
	V 30	52.63	7.17	44.87	6.71	40.27	7.12	41.31	7.71	0.020	A vs C and D
	V 35	41.72	6.78	33.35	6.13	30.06	6.43	31.14	6.73	0.010	A vs B,C and D
	V 40	28.82	5.67	21.54	5.10	19.94	7.27	20.67	5.24	0.020	A vs B,C and D
	V 45	9.16	3.51	7.64	2.75	7.20	2.83	6.91	2.21	NS
ACTLSBM	D max	48.46	2.01	48.66	1.51	49.08	1.70	49.13	1.54	NS
	D mean	37.86	18.56	27.87	4.38	27.35	4.65	27.65	4.40	NS
	V 5	89.89	8.72	87.71	9.16	87.24	9.48	87.43	9.30	NS
	V 10	83.87	8.66	79.88	9.49	79.18	10.58	79.32	10.03	NS
	V 15	79.94	9.09	74.87	9.99	74.19	11.68	74.46	10.64	NS
	V 20	77.23	9.44	68.80	11.31	67.97	13.53	68.45	11.75	NS
	V 25	73.13	10.15	60.88	12.60	59.46	14.15	60.71	12.54	NS
	V 30	66.53	11.19	52.06	13.20	50.07	13.19	51.46	12.97	0.020	A vs B,C and D
	V 35	56.95	12.73	42.15	12.79	40.19	11.90	41.42	12.30	0.010	A vs B,C and D
	V 40	41.04	14.37	29.81	10.52	28.17	9.40	29.29	9.72	0.050	A vs C
	V 45	16.11	12.75	10.53	5.13	9.48	3.92	9.23	3.74	NS

Legend: D _max maximal dose, D _mean mean dose, SD standard deviation, V _{5,10,15,20,25,30,35,40,45} relative volume receiving 5,10,15,20,25,30,35,40,45 Gy, PBM pelvic bone marrow, LSBM lumbar-sacral bone marrow, ^ACT active, A, B, C, D plan A,B,C, D, NS non significant